← All patents

US20250222067A1

Treatment for Ocular Fibrosis

University of North Texas Health Science Center

Abstract

The present invention includes methods of treating ocular fibrosis of the eye in a human subject, the method comprising administering to the human subject in need of treatment a therapeutically effective amount of a prolactin-inducible Protein (PIP) which is capable of inhibiting or reversing the …

University
University of North Texas Health Science Center
Assignee
University Of North Texas Health Science Center At Fort Worth
Inventor
Dimitrios Karamichos
Priority date
April 08, 2022
Filing date
April 07, 2023
Publication date
July 10, 2025
Language
en
Metadata fetched
August 28, 2026 19:12